Arcadia Biosciences, Inc.
RKDA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,120 | $1,376 | $3,159 | $4,242 |
| Short-Term Investments | $4,765 | $3,067 | $0 | $0 |
| Receivables | $831 | $1,264 | $3,579 | $1,175 |
| Inventory | $1,457 | $1,489 | $1,285 | $904 |
| Other Curr. Assets | $0 | $0 | $823 | $1,990 |
| Total Curr. Assets | $8,387 | $7,579 | $8,846 | $9,242 |
| Property Plant & Equip (Net) | $10 | $22 | $47 | $178 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $39 | $39 | $39 | $39 |
| Long-Term Investments | $0 | $0 | $3,966 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $148 | $148 | $92 | $4,058 |
| Total NC Assets | $197 | $209 | $4,144 | $4,275 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $8,584 | $7,788 | $12,990 | $13,517 |
| Liabilities | – | – | – | – |
| Payables | $2,015 | $1,558 | $1,895 | $703 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $270 | $270 | $270 | $483 |
| Total Curr. Liab. | $2,285 | $1,839 | $2,216 | $2,563 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $856 | $1,416 | $1,869 | $4,731 |
| Total NC Liab. | $856 | $1,416 | $1,869 | $4,731 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $11 | $21 | $155 |
| Total Liabilities | $3,141 | $3,255 | $4,085 | $7,294 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $65 | $65 | $65 | $65 |
| Retained Earnings | -$279,881 | -$280,737 | -$276,279 | -$278,878 |
| AOCI | -$0 | $0 | $0 | $0 |
| Other Equity | $0 | -$0 | $0 | $0 |
| Total Equity | $5,443 | $4,533 | $8,905 | $6,223 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $8,584 | $7,788 | $12,990 | $13,517 |
| Net Debt | -$1,120 | -$1,376 | -$3,159 | -$4,242 |